- ESIP recommendations on digitalisation of social security coordination in Europe, 06.11.23 (PDF, 230 KB)
- Joint ESIP-MEDEV Position Paper on The Revision of the EU Pharmaceutical Legislation European Social Insurance Platform (ESIP) Medicine Evaluation Committee (MEDEV), 06.11.2023 (PDF, 453 KB)
- ESIP-MEDEV position on the Revision of the EU legislation on orphan medicinal products (PDF, 354 KB)
- ESIP-MEDEV admendments position on the Revision of the EU legislation on orphan medicinal products (PDF, 226 KB)
- ESIP feedback to the call for evidence on the European Care Strategy, 29.03.2022 (PDF, 238 KB)
- ESIP reflection paper on Cancer comorbidities and complications: proposals for a new approach for health insurers, 12.07.2021 (PDF, 362 KB)
- Feedback of the European Social Insurance Platform (ESIP) to the Evaluation roadmap/Inception Impact Assessment on the revision of the EU pharmaceutical legislation, 27.04.2021 (PDF, 197 KB)
- Green Paper on Ageing, ESIP replies to the public consultation, 21.04.2021 (PDF, 260 KB)
- ESIP position paper on Preventing and Managing Shortages of Medical Devices and Personal Protective Equipment, 24.02.2021 (PDF, 389 KB)
- ESIP feedback to the Inception Impact Assessment of the new European Health Emergency Preparedness and Response Authority, 24.02.2021 (PDF, 245 KB)
- European Health Emergency Preparedness and Response Authority (HERA). Feedback on the Inception Impact Assessment from the German Social Insurance European Representation, 19.02.2021 (PDF, 442 KB)
- Feedback of the European Social Insurance Platform (ESIP) on the Combined Evaluation Roadmap/Inception Impact Assessment on a European Health Data Space, 03.02.2021 (PDF, 249 KB)
- ESIP feedback to the proposal for a Regulation on serious cross-border threats to health and repealing Decision No 1082/2013/EU, 02.02.2021 (PDF, 218 KB)
- ESIP feedback to the proposal for a Regulation on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices, 02.02.2021 (PDF, 216 KB)
- Opinion of the German Social Insurance "A pharmaceutical strategy for Europe", 20th January 2021 (PDF, 406 KB)
- Feedback of the European Social Insurance Platform (ESIP) on the Inception Impact Assessment on a revision of the EU legislation on medicines for children and rare diseases, ESIP, 07.01.2021 (PDF, 219 KB)
- European Pillar of Social Rights – ESIP response to the consultation on the Action Plan, 26. November 2020 (PDF, 367 KB)
- The European Pillar of Social Rights, Discussion paper of the German Social Insurance, 26 November 2020 (PDF, 401 KB)
- ESIP Position Paper on Preventing and Managing Medicine Shortages, 29.09.2020 (PDF, 291 KB)
- ESIP feedback to the roadmap on a legislative framework for the governance of common European data spaces, 31.07.2020 (PDF, 203 KB)
- ESIP feedback to the Pharmaceutical Strategy Roadmap, 07.07.2020 (PDF, 187 KB)
- Antimicrobial Resistance (AMR), Position Paper of the European Social Insurance Platform (ESIP), 23.06.2020 (PDF, 314 KB)
- Comments by the German Social Insurance on the European Commission’s public consultation on Europe’s Beating Cancer Plan, 02.05.2020 (PDF, 390 KB)
- Statement of the GKV-Spitzenverband on high quality medical devices: Ensuring security of supply in Europe even during COVID-19 pandemic. (26.03.2020) (PDF, 55 KB)
- Statement from the German Social Insurance on the Communication from the European Commission on more efficient decision-making in social policy: identification of areas for an enhanced move to qualified majority voting, 30.08.2019 (PDF, 146 KB)
- Digital Transformation of Health and Care, Position Paper of the European Social Insurance Platform (ESIP), 14.06.2019 (PDF, 323 KB)
- Review of Regulation (EC) No 141/2000 on Orphan Medicinal Products (OMP) - Position Paper of the European Social Insurance Platform (ESIP), 30 May 2019 (PDF, 321 KB)
- Open Letter to the Romanian Presidency on the proposal for a Regulation on Health Technology Assessment (HTA) by the European Social Insurance Platform (ESIP), 21.01.2019 (PDF, 262 KB)
- Comments from the National Association of Statutory Health Insurance Funds to the European Ombudsman’s inquiry: How the European Medicines Agency engages with medicine producers before they apply for authorisations to market their medicines in the EU (18.12.2018) (PDF, 62 KB)
- Statement of the European Social Insurance Platform (ESIP) supporting the inclusion of a broad scope of medical devices in the proposed Regulation, 6 July 2018 (PDF, 288 KB)
- Reflections of the GKV-Spitzenverband on the Draft Report by the European Parliament Committee on Environment, Public Health and Food Safety on the proposal for a Regulation on Health Technology Assessment (01.06.2018) (PDF, 322 KB)
- Statement of the European Social Insurance Platform (ESIP) on the Draft Report of the European Parliament’s ENVI committee on the Regulation on Health Technology Assessment (08.06.2018) (PDF, 367 KB)
- Comments from the National Association of Statutory Health Insurance Funds from 08.05.2018: Proposal for a Regulation on health technology assessment and amending Directive 2011/24/EU (HTA) (PDF, 343 KB)
- Avis de la fédération GKV-Spitzenverband du 08.05.2018: Proposition de règlement concernant l’évaluation des technologies de la santé et modifiant la directive 2011/24/UE (HTA) (PDF, 406 KB)
- Avis du GKV-Spitzenverband du 02.05.2017 relatif à la proposition pour un règlement modifiant le règlement (CE) N° 883/2004 portant sur la coordination des systèmes de sécurité sociale et le règlement (CE) N° 987/2009 fixant les modalités d’application du règlement (CE) N° 883/2004 du 13.12.2016 (PDF, 531 KB)
- Statement by the German National Association of Statutory Health Insurance Funds of 2 May 2017 on the Proposal for a Regulation amending Regulation (EC) No 883/2004 on the coordination of social security systems and Regulation (EC) No 987/2009 laying down the procedure for implementing Regulation (EC) No 883/2004 of 13 December 2016 (PDF, 428 KB)
- Statement of the European Social Insurance Platform (ESIP) on Long-term care benefits, 3 January 2017 (PDF, 536 KB)
- Position of the European Social Insurance Platform (ESIP): Revision of Regulation (EC) No 726/2004, 25.11.2016 (PDF, 437 KB)
- Comments by the National Association of Statutory Health Insurance Funds to the Public Consultation on the safety of apps and other non-embedded software, 13.09.2016 (PDF, 194 KB)
- Comments of the National Association of Statutory Health Insurance Funds to the Public Consultation on the European Pillar of Social Rights, 24.08.2016 (PDF, 298 KB)
- Annual Report 2014 (PDF, 5,4 MB)
- Proposal for a Regulation on Medical Devices, Current negotiations in the Council of the European Union, Position of the ESIP, 26.05.2015 (PDF, 172 KB)
- The Role of Social insurance institutions in the prevention of alcohol-related harm in Europe - Survey of the ESIP, 24.04.2015 (PDF, 595 KB)
- Proposal for a Regulation on Medical Devices, Current negotions in the Council of the European Union, Position of statutory health an long-term care insurance, 02.04.2015 (PDF, 70 KB)
- ESIP response to the public consultation of the European Commission on the Green Paper on mobile Health ("mHealth") (PDF, 181 KB)
- Written Contribution of the National Association of Statutory Health Insurance Funds to the Public Consultation of the European Commission on the Green Paper on mobile Health (mHeath), 27.06.2014 (PDF, 111 KB)
- Written Contribution of the National Association of Statutory Health Insurance Funds of 26.02.2014 to the Public Consultation on Patient Safety and Quality of Care of the European Commission (PDF, 85 KB)
- European Commission proposal for a Directive of the European Parliament and of the Council relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of the public health insurance system COM(2012) 84 (PDF, 285 KB)